Efficacy and Safety of Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: Evidence from Randomized Controlled Trials.
Mult Scler Relat Disord
; 43: 102166, 2020 Aug.
Article
in En
| MEDLINE
| ID: mdl-32442886
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neuromyelitis Optica
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2020
Type:
Article